Inflammatory bowel disease versus irritable bowel syndrome: a hospital‐based, case‐control study of disease impact on quality of life

2003 ◽  
Vol 38 (10) ◽  
pp. 1031-1038 ◽  
Author(s):  
F. Pace ◽  
P. Molteni ◽  
S. Bollani ◽  
P. Sarzi‐Puttini ◽  
R. Stockbrügger ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Inflammatory Bowel Disease ◽  
Irritable Bowel Syndrome ◽  
Case Control Study ◽  
Case Control ◽  
Disease Impact ◽  
Inflammatory Bowel ◽  
Irritable Bowel ◽  
Control Study

scholarly journals The Clinical Accuracy of the BÜHLMANN fCAL ELISA in the Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome: A Multicenter Prospective Case–Control Study

2019 ◽  
Vol 1 (3) ◽  
Author(s):  
Jeffrey A Berinstein ◽  
Calen A Steiner ◽  
Athos Bousvaros ◽  
Felix P Tiongco ◽  
Eugene Greenberg ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Irritable Bowel Syndrome ◽  
Bowel Disease ◽  
Case Control Study ◽  
Case Control ◽  
Enzyme Linked Immunosorbent Assay ◽  
Inflammatory Bowel ◽  
Irritable Bowel ◽  
Control Study ◽  
Prospective Case Control Study

Abstract Background Fecal calprotectin (fCAL) is a noninvasive biomarker used to differentiate between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). Methods A multicenter prospective case–control study evaluating the BÜHLMANN fCAL enzyme-linked immunosorbent assay (ELISA) was conducted in 478 subjects. Sensitivity, specificity, predictive values, and area under the receiver operator characteristic (AuROC) curve are reported and compared to another device. Results In differentiating IBD from IBS, the BÜHLMANN fCAL ELISA is very sensitive (93.3%) at a cutoff <80 μg/g and balanced sensitivity (84.4%) and specificity (85.4%) at a cutoff >160 μg/g (AuROC 0.933). Conclusions The BÜHLMANN fCAL ELISA demonstrates excellent discriminating between IBD and IBS.

scholarly journals Health related quality of life in irritable bowel syndrome patients, Kashan, Iran: A case control study

2015 ◽  
Vol 4 (1) ◽  
pp. 75 ◽  
Author(s):  
Mostafa Raisi ◽  
Mohammad Matini ◽  
Alireza Moravveji ◽  
Abdollah Omidi ◽  
Jaleh Amini ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Irritable Bowel Syndrome ◽  
Case Control Study ◽  
Case Control ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related ◽  
Irritable Bowel ◽  
Control Study

A Comparative Study of Quality of Life in Persons With Irritable Bowel Syndrome and Inflammatory Bowel Disease

2015 ◽  
Vol 38 (4) ◽  
pp. 268-278 ◽  
Author(s):  
Sarah Blagden ◽  
Thomas Kingstone ◽  
Andrew Soundy ◽  
Rhonda Lee ◽  
Sukhdev Singh ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Inflammatory Bowel Disease ◽  
Irritable Bowel Syndrome ◽  
Comparative Study ◽  
Bowel Disease ◽  
Inflammatory Bowel ◽  
Irritable Bowel

scholarly journals Endometriosis intestinal, una causa de suboclusión intestinal poco sospechada. Serie de casos

2021 ◽  
Vol 51 (4) ◽  
Author(s):  
Tomas Pérez ◽  
Romina Lorena Alsina Farreta ◽  
María Laura González ◽  
Analía Verónica Pasqua ◽  
María Josefina Sobrero ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Inflammatory Bowel Disease ◽  
Irritable Bowel Syndrome ◽  
Deep Infiltrating Endometriosis ◽  
Endometriotic Lesion ◽  
Inflammatory Bowel ◽  
Therapeutic Behavior ◽  
Irritable Bowel ◽  
Infiltrating Endometriosis

Endometriosis is defined as the presence of endometrial glands in extrauterine sites. Intestinal deep infiltrating endometriosis is considered when the endometriotic lesion is located more than 5 mm below the peritoneum. Intestinal obstruction due to endometriosis is rare, occurring in approximately 1% of cases. We present three cases with intestinal occlusion as deep infiltrating endometriosis debut. Its symptomatic presentation can mimic multiple gastroenterological entities, mainly irritable bowel syndrome or inflammatory bowel disease so its diagnosis can be difficult. However, suspecting this pathology and diagnosing it is important to define therapeutic behavior and improve the quality of life of our patients.

Quality of Life (QOL) in Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS)

2006 ◽  
Vol 101 ◽  
pp. S414-S415
Author(s):  
Tiffany N. Havlicek ◽  
Jason Bratten ◽  
Margo Klein ◽  
Laurie Keefer ◽  
Michael P. Jones
Keyword(s):  
Quality Of Life ◽  
Inflammatory Bowel Disease ◽  
Irritable Bowel Syndrome ◽  
Bowel Disease ◽  
Inflammatory Bowel ◽  
Irritable Bowel
Sign in / Sign up

Export Citation Format

Share Document